Submit your email to push it up the queue
Sunrise Medical Laboratories, Inc., a prominent name in the clinical laboratory industry, is headquartered in the United States. Founded in 1993, the company has established itself as a leader in providing comprehensive laboratory testing services across various operational regions, including the Northeast and Midwest. Specialising in a wide array of diagnostic tests, Sunrise Medical Laboratories offers unique services such as advanced molecular diagnostics and toxicology testing, setting them apart in a competitive market. Their commitment to quality and innovation has earned them a strong market position, recognised for their rapid turnaround times and exceptional customer service. With a focus on enhancing patient care, Sunrise Medical Laboratories continues to achieve notable milestones in the healthcare sector.
How does Sunrise Medical Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sunrise Medical Laboratories, Inc.'s score of 55 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sunrise Medical Laboratories, Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Sonic Healthcare Limited, which may influence its climate commitments and reporting practices. As part of its corporate family, Sunrise Medical Laboratories inherits climate-related initiatives and performance metrics from Sonic Healthcare Limited. However, there are no documented reduction targets or specific climate pledges available for Sunrise Medical Laboratories at this time. The absence of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it is essential for Sunrise Medical Laboratories to establish clear emissions reduction targets and commitments to align with global climate goals.
Access structured emissions data, company-specific emission factors, and source documents
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|
Scope 1 | 8,124,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 59,156,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sunrise Medical Laboratories, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.